NCT03101254 2024-07-17LY3022855 With BRAF/MEK Inhibition in Patients With MelanomaDana-Farber Cancer InstitutePhase 1/2 Completed5 enrolled 10 charts
NCT01512251 2020-08-17BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced MelanomaUniversity of California, San FranciscoPhase 1/2 Completed8 enrolled 6 charts
NCT02354690 2020-03-23Vemurafenib and TIL Therapy for Metastatic MelanomaHerlev HospitalPhase 1/2 Completed13 enrolled 12 charts